P3355
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate CancerHormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate CancerTriptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerFlutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the ProstateAssessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen SuppressionAntiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryHormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerEffects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and ProgesteroneThree Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal HyperplasiaStandard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerRadiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyLeuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate CancerEffect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian CancerStudy on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate CancerFinite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Participants With Recurrent Prostate CancerTreatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate AdenocarcinomaRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerEffect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary SyndromeIntermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,cRadiation Therapy and Hormone Therapy in Treating Patients With Prostate CancerGoserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerEffects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary SyndromeAndrogen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate CancerEffectiveness of Flutamide in Treating Women With Premenstrual Dysphoric DisorderA Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate CancerA Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate CancerAn Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the ProstateMetabolic Syndrome in PCOS: Precursors and InterventionsProstate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for ProstatExternal Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate CancerEffects of IAS in Men With Localized Biochemical Relapsed Prostate CancerHormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate CancerFlutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate CancerStudy of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate CancerRadiation Therapy With Androgen Suppression in Treating Patients With Prostate CancerCombination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate CancerRadiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerHormone Therapy in Treating Patients With Prostate CancerSU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerRandomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
P4844
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Flutamid
@de
Flutamid
@pl
Flutamid
@sh
Flutamid
@sr
Flutamida
@es
Flutamide
@it
Flutamide
@nl
Flutamide
@vi
Flutamidi
@fi
fflwtamid
@cy
type
label
Flutamid
@de
Flutamid
@pl
Flutamid
@sh
Flutamid
@sr
Flutamida
@es
Flutamide
@it
Flutamide
@nl
Flutamide
@vi
Flutamidi
@fi
fflwtamid
@cy
altLabel
4'-Nitro-3'-trifluoromethylisobutyranilide
@en
4'-nitro-3'-trifluoromethylisobutyranilide
@cy
4'-nitro-3'-trifluoromethylisobutyranilide
@en
Eulexin
@cy
Eulexin
@en
Eulexin
@it
Eulexin®
@cy
Eulexin®
@en
FTA
@en
Flutamid
@en
prefLabel
Flutamid
@de
Flutamid
@pl
Flutamid
@sh
Flutamid
@sr
Flutamida
@es
Flutamide
@it
Flutamide
@nl
Flutamide
@vi
Flutamidi
@fi
fflwtamid
@cy